CD79A and infection: The IgG, IgA and nAb levels were significantly lower in individuals who would experience a future infection than those who did not after the 12-month collection round (p = 0.009, p = 0.031, and p = 0.028 for IgG, IgA and nAb levels, respectively, Fig. 8).